Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Manuel Ramos-Casals & Pilar Brito-Zerón. (2007) New approaches in Sjögren’s syndrome therapy. Expert Review of Clinical Immunology 3:2, pages 195-204.
Read now
Read now
S. J. Bowman. (2002) Collaborative research into outcome measures in Sjögren's syndrome. Scandinavian Journal of Rheumatology 31:sup116, pages 23-27.
Read now
Read now
Robert L. Fox & Michael Stern. (2002) Sjögren's syndrome: mechanisms ofpathogenesis involve interaction of immune and neurosecretory systems. Scandinavian Journal of Rheumatology 31:sup116, pages 3-13.
Read now
Read now
Articles from other publishers (24)
Akiko Tanaka, Hiroyuki Nakano, Kunio YonetoChika YonetoTomoyuki Furubayashi, Kei Suzuki, Azusa Okae, Takaaki Ueno & Toshiyasu Sakane. (2022) Topical Xerostomia Treatment with Hyaluronate Sheets Containing Pilocarpine. Biological and Pharmaceutical Bulletin 45:4, pages 403-408.
Crossref
Crossref
Manuel Hawner & Christian Ducho. (2020) Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules. Molecules 25:24, pages 5963.
Crossref
Crossref
Takanori Narita, Bing Qi, Masataka Murakami & Hiroshi Sugiya. (2019) Pilocarpine induces the residual secretion of salivary fluid in perfused submandibular glands of rats. PLOS ONE 14:8, pages e0221832.
Crossref
Crossref
Yevgeniy Popov & Karen Salomon-Escoto. (2018) Gastrointestinal and Hepatic Disease in Sjogren Syndrome. Rheumatic Disease Clinics of North America 44:1, pages 143-151.
Crossref
Crossref
Scarlette Agbo-Godeau, Aline Guedj, Sabine Marès & Patrick Goudot. (2017) Sécheresse buccale (xérostomie). La Presse Médicale 46:3, pages 296-302.
Crossref
Crossref
John Hamburger. (2016) Orofacial manifestations in patients with inflammatory rheumatic diseases. Best Practice & Research Clinical Rheumatology 30:5, pages 826-850.
Crossref
Crossref
Cai-Qi Cheng, Hao Xu, Ling Liu, Rui-Nan Wang, Yu-Ting Liu, Jing Li & Xi-Kun Zhou. (2016) Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer. The Journal of the American Dental Association 147:4, pages 236-243.
Crossref
Crossref
Vladimir Vsevolodovich Brjesky & Mukhammed Radukhan. (2014) Glaucoma and the dry eye syndrome. Ophthalmology Reports 7:2, pages 37-49.
Crossref
Crossref
Osama M. A. Ibrahim, Murat Dogru, Shinichi Kawashima, Tais H. Wakamatsu, Kazuo Tsubota & Hiroshi Fujishima. (2013) Visante Optical Coherence Tomography and Tear Function Test Evaluation of Cholinergic Treatment Response in Patients With Sjögren Syndrome. Cornea 32:5, pages 653-657.
Crossref
Crossref
Raveendra S. Morchi. 2013. Emergency Medicine. Emergency Medicine
949
958.e1
.
Peng Yu, Guoping Yang, Hongyi Tan, Zeneng Cheng, Ming Song, Zhenkun Gu & Xiao Li. (2011) Determination of Pilocarpine in Human Plasma by LC–APCI–MS–MS and Application to a Pharmacokinetic Study. Chromatographia 73:9-10, pages 921-927.
Crossref
Crossref
Robert I. Fox & Carla M. Fox. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome
517
545
.
MA Braga, O Tarzia, CC Bergamaschi, FA Santos, ED Andrade & FC Groppo. (2009) Comparison of the effects of pilocarpine and cevimeline on salivary flow. International Journal of Dental Hygiene 7:2, pages 126-130.
Crossref
Crossref
GARY N. FOULKS. 2008. Ocular Therapeutics. Ocular Therapeutics
119
132
.
Hubertus Seitsalo, Raija K Niemelä, Magdalena Marinescu-Gava, Tuija Vuotila, Leo Tjäderhane & Tuula Salo. (2007) Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's Syndrome: a randomized, double-blind, placebo controlled cross-over study. Journal of Negative Results in BioMedicine 6:1.
Crossref
Crossref
P.J. Venables. (2006) Management of patients presenting with Sjogren's syndrome. Best Practice & Research Clinical Rheumatology 20:4, pages 791-807.
Crossref
Crossref
Stefano Bombardieri & Chiara Baldini. 2006. The Skin in Systemic Autoimmune Diseases. The Skin in Systemic Autoimmune Diseases
147
160
.
Cheng-Han Wu, Song-Chou Hsieh, Kuang-Lun Lee, Chia-Li Yu, Ko-Jen Li & Ming-Chi Lu. (2006) Pilocarpine Hydrochloride for the Treatment of Xerostomia in Patients with Sjögren's Syndrome in Taiwan—A Double-blind, Placebo-controlled Trial. Journal of the Formosan Medical Association 105:10, pages 796-803.
Crossref
Crossref
Juan Murube. (2005) Pilocarpine and Tear Secretion. The Ocular Surface 3:3, pages 119-125.
Crossref
Crossref
Michael Samarkos & Haralampos M. Moutsopoulos. (2005) Recent advances in the management of ocular complications of sjögren’s syndrome. Current Allergy and Asthma Reports 5:4, pages 327-332.
Crossref
Crossref
J Hamburger. (2004) Sjögren's syndrome – managing oral and systemic symptoms via a multi‐disciplinary approach*. Oral Diseases 10:5, pages 306-309.
Crossref
Crossref
Vidya Sankar, Michael T. Brennan, Marc R. Kok, Rose Anne Leakan, Janine A. Smith, Joan Manny, Bruce J. Baum & Stanley R. Pillemer. (2004) Etanercept in Sjögren's syndrome: A twelve‐week randomized, double‐blind, placebo‐controlled pilot clinical trial. Arthritis & Rheumatism 50:7, pages 2240-2245.
Crossref
Crossref
Robert G Hendrickson, Anthony P Morocco & Michael I Greenberg. (2004) Pilocarpine toxicity and the treatment of xerostomia. The Journal of Emergency Medicine 26:4, pages 429-432.
Crossref
Crossref
S.R Porter, C Scully & A.M Hegarty. (2004) An update of the etiology and management of xerostomia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 97:1, pages 28-46.
Crossref
Crossref